HCC is a highly-vascularized, neoplastic disease with rapid growth and repetitive vascular invasion, and the process of angiogenesis could be a target for novel prognostic and therapeutic approaches to HCC, involving VEGF [64]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.